Chinese genetic sequencing firm Novogene sues the US Pentagon over its inclusion on a military blacklist/designation, the company says the move is unwarranted and has harmed its business.

Novogene argues it has no military ties and denies that it designs, develops, or markets products for military use. In court filings described by outlets, the company points to its US operations, including a Sacramento office and sequencing facilities in Sacramento, California, and Beaverton, Oregon, and says the Pentagon’s action has caused economic and reputational harm. The reports emphasise different aspects: one outlet highlights the scale and location of Novogene’s US workforce and facilities, while another frames the dispute more generally around the military designation.

Overall, both accounts describe the lawsuit as Novogene’s legal challenge to the Pentagon’s decision and its stated grounds for contesting the designation.